References
- Ritter J, Bielack SS. Osteosarcoma. Ann Oncol. 2010;21(Suppl. 7):vii320–vii325. doi:10.1093/annonc/mdq276
- Maugg D, Rothenaigner I, Schorpp K, et al. New small molecules targeting apoptosis and cell viability in osteosarcoma. PLOS ONE. 2015;10(6):e0129058. doi:10.1371/journal.pone.0129058
- Regan DP, Chow L, Das S, et al. Losartan blocks osteosarcoma-elicited monocyte recruitment and combined with the kinase inhibitor toceranib, exerts significant clinical benefit in canine metastatic osteosarcoma. Clin Cancer Res: Official J Am Assoc Cancer Res. 2022;28(4):662–676. doi:10.1158/1078-0432.CCR-21-2105
- Todaro M, Gaggianesi M, Catalano V, et al. CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell. 2014;14(3):342–356. doi:10.1016/j.stem.2014.01.009
- Xie Z, Gao Y, Ho C, et al. Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment. Gut. 2022;71(3):568–579. doi:10.1136/gutjnl-2020-323014
- Wang Z, Zhao K, Hackert T, Zöller M. CD44/CD44v6 a reliable companion in cancer-initiating cell maintenance and tumor progression. Front Cell Dev Biol. 2018;6:97. doi:10.3389/fcell.2018.00097
- Hosseini A, Eghtedari AR, Mirzaei A, et al. The clinical significance of CD44v6 in malignant and benign primary bone tumors. BMC Musculoskelet Disord. 2023;24(1):607. doi:10.1186/s12891-023-06738-7
- Ji H, Kong L, Wang Y, et al. CD44 expression is correlated with osteosarcoma cell progression and immune infiltration and affects the Wnt/β-catenin signaling pathway. J Bone Oncol. 2023;41:100487. doi:10.1016/j.jbo.2023.100487
- Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2(3):161–174. doi:10.1038/nrc745
- Liu D, Kang H, Gao M, et al. Exosome-transmitted circ_MMP2 promotes hepatocellular carcinoma metastasis by upregulating MMP2. Mol Oncol. 2020;14(6):1365–1380. doi:10.1002/1878-0261.12637
- Roy R, Yang J, Moses MA. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol. 2009;27(31):5287–5297. doi:10.1200/JCO.2009.23.5556
- Bauvois B. New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim Biophys Acta. 2012;1825(1):29–36. doi:10.1016/j.bbcan.2011.10.001
- Meyers PA, Heller G, Healey J, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol. 1992;10(1):5–15. doi:10.1200/JCO.1992.10.1.5
- Kuryu M, Ozaki T, Nishida K, Shibahara M, Kawai A, Inoue H. Expression of CD44 variants in osteosarcoma. J Cancer Res Clin Oncol. 1999;125(11):646–652. doi:10.1007/s004320050329
- Zhang M, Zhang X. Association of MMP-2 expression and prognosis in osteosarcoma patients. Int J Clinical Experimental Pathology. 2015;8(11):14965–14970.
- Biermann JS, Chow W, Reed DR, et al. NCCN guidelines insights: bone cancer, version 2.2017. J National Comprehensive Cancer Network: JNCCN. 2017;15(2):155–167. doi:10.6004/jnccn.2017.0017
- Chen C, Zhao S, Karnad A, Freeman JW. The biology and role of CD44 in cancer progression: therapeutic implications. J Hematol Oncol. 2018;11(1):64. doi:10.1186/s13045-018-0605-5
- Ni J, Cozzi PJ, Hao JL, et al. CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance. Prostate. 2014;74(6):602–617. doi:10.1002/pros.22775
- Cho HJ, Lee TS, Park JB, et al. Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression. J Biochem Mol Biol. 2007;40(6):1069–1076. doi:10.5483/BMBRep.2007.40.6.1069
- Li Z, Li H, Chen J, et al. SPAG5 promotes osteosarcoma metastasis via activation of FOXM1/MMP2 axis. Int J Biochem Cell Biol. 2020;126:105797. doi:10.1016/j.biocel.2020.105797
- Liao CL, Lai KC, Huang AC, et al. Gallic acid inhibits migration and invasion in human osteosarcoma U-2 OS cells through suppressing the matrix metalloproteinase-2/-9, protein kinase B (PKB) and PKC signaling pathways. Food Chem Toxicol. 2012;50(5):1734–1740. doi:10.1016/j.fct.2012.02.033
- Wang L, Duan W, Kang L, et al. Smoothened activates breast cancer stem-like cell and promotes tumorigenesis and metastasis of breast cancer. Biomed Pharmacother. 2014;68(8):1099–1104. doi:10.1016/j.biopha.2014.09.012